Mefloquine monitoring in acute uncomplicated malaria treated with Fansimef and Lariam.
Southeast Asian J Trop Med Public Health
;
1993 Jun; 24(2): 221-5
Article
Dans Anglais
| IMSEAR
| ID: sea-35597
ABSTRACT
Mefloquine levels were compared between Plasmodium falciparum malaria patients with sensitive response and those with treatment failure who received 3 drug regimens of mefloquine (46 patients with MSP 3 tablets (Fansimef), 38 and 34 with mefloquine (Lariam) 750 mg and 1,250 mg). Mefloquine concentrations on Day-1 in any regimens in patients with treatment failure were significantly lower than those from the sensitive response, whereas there was no difference in the concentrations on Day-7. However, MIC values of mefloquine prior to drug treatment were comparable in both groups. The study suggests that pre-treatment in vitro sensitivity testing was a non-reliable indicator of clinical outcome. Mefloquine concentration on the first day after treatment is a better predictor of the treatment outcome.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Pyriméthamine
/
Sulfadoxine
/
Humains
/
Mâle
/
Méfloquine
/
Maladie aigüe
/
Adolescent
/
Paludisme à Plasmodium falciparum
/
Adulte
/
Association médicamenteuse
Type d'étude:
Étude pronostique
langue:
Anglais
Texte intégral:
Southeast Asian J Trop Med Public Health
Année:
1993
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS